Skip to main content

Closed

ATYR: aTyr Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-33.4% / yr

Operating margin-38573.7%

ROIC-105.5%

Financially safe

Stretched

Debt / equity0.20×

Interest coverage0.0×

Current ratio5.78×

aTyr Pharma, Inc.

ATYRNASDAQ Global Market·USD·Closed

aTyr Pharma, Inc.

ATYRNASDAQ·USD·Closed

$0.49

+1.19%

$0.49

+$0.01 (1.19%)

52W Range

1thpctl

Volume

0.14×avg

Mkt Cap

47.62MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.14×avg

Market Cap

47.62MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings